- Vechain exceeds IBM by using IoT sensors to pursue medication in every phase of the supply chain.
- Fairchain follows every step of a drug development and ensures the adequate use of biofoams and compliance with the Nagoya protocol.
The Toolchain von Vechain is a leader in the field of pharmaceutical trace and has in a “Electronics” in June 2025 in June 2025 published Study Four other large blockchain platforms-IBM Pharma Ledger, Mediledger, Pharmitedger and Hyperledger Fabric-exceeded.
The evaluation confirmed that VECHAIN is the only system that has successfully integrated blockchains with IoT sensors such as NFC and RFID for real-time verification in the entire pharmaceutical supply chain.
Another MAJOR academic win for #VeChain
In Electronics (June 2025), #VeChain’s ToolChain is highlighted as a standout in pharmaceutical tracking — beating out IBM, Hyperledger, and others:
“VeChain uniquely integrates IoT-based tracking mechanisms (NFC and RFID) for… pic.twitter.com/b57Wxi4z2O
— Sebastian.vet Ⓥ
(@PERE_Mainz) June 30, 2025
The main feature of the platform is its ability to pursue and authenticate medication over their entire life cycle, from production to delivery. Toolchain supports compliance with legal regulations with this ability and helps prevent the global spread of fake medication. The study found that Toolchain’s system is more transparent and safer than the systems of competitors.
The support of Bayer also confirms this service. The pharmaceutical giant chose Toolchain for its CSecure program to pursue clinical medication with time-stamped data. This step underlines the trust that the large actors in Toolchains combined use of blockchain and IoT technology to protect drug sales.
Number of drug falsifications rose sharply during Covid
The COVID-19 pandemic left a major impact with around 700 million infection cases and 7 million deaths worldwide. Under these circumstances, the increasing production of fake drugs became a serious challenge. The drug manufacturers and the health authorities reacted to this by introducing safe systems for tracing medicines. The United Nations development program intervened with the Nagoya protocol, which aims to use fair use and the advantage of genetic resources for drug production.
Fairchain comes in at this point. It was created as a digital health system that is based on the principles of the Nagoya protocol and pursues all steps of the life cycle of drug development (DDLC). The DDLC includes everything from sampling to the clinical test to market registration. Fairchain makes every step transparent by using the blockchain to record all activities in an unchangeable ledger.
The system enables pharmaceutical companies to document all the details of drug production. In addition, there are landowners control of how bio samples are used by their country, enables regulatory authorities to monitor the process and support the common use of data by researchers. Fairchain is the first solution that combines traceability, auditability and legal conformity in a single blockchain solution that covers the entire development cycle.
Fairchain pursues compliance with the Nagoya protocol
Research data show that pharmaceutical innovations increase life expectancy by 0.75 % to 1.0 %. In the United States, 33 % of the increase in life expectancy between 1990 and 2015 is due to drug development. This progress could be lost if the innovation slows down. Fairchain encounters this risk by ensuring the property and use of bio samples that protects participants and guarantees fair compensation.
The platform, which was launched in 2010 to support the Nagoya Protocol, records the origin and use of every bio sample and ensures that donors from indigenous communities are not left out. The protocol also ensures a fair division of financial and non-financial advantages of commercial drugs that use these natural resources. The compensation can include cash payments, profit sharing or technology transfer.
The system protects both the communities of origin and the pharmaceutical companies. It strengthens the ethical supervision of the 8- to 12-year process from start to finish. The use of the blockchain by Fairchain also eliminates problems that often occur in centralized systems, such as: B. Data manipulation or losses, since the main register is distributed to several nodes.
In contrast to Mediledger or Blockpharma, Fairchain records all six phases of drug development in intelligent contracts and encrypted storage. It ensures transparency, fair access and compliance with legal regulations – characteristics that are missing in systems such as hyperledger. Developed with Saudi experts, it expands Vechain’s focus on the supply chain by emphasizing fairness and traceability from the origin.
No Comments